Laboratory criteria of the obstetrical antiphospholipid syndrome: Data from a multicentric prospective European women cohort

Thrombosis and Haemostasis

Volumn 102, Issue 1, 2009, Pages 25-28

  Boffa, Marie Claire ^a   Boinot, Catherine ^b   De Carolis, Sara ^c   Rovere Querini, Patrizia ^d   Aurousseau, Marie Hélène ^a   Allegri, Flavio ^e   Nicaise Roland, Pascale ^a,f   Barra, Anne ^b   Botta, Angela ^c   Ambrozic, Ales ^g   Avcin, Tadej ^g   Tincani, Angela ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c CATHOLIC UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Anti beta2 glycoprotein I antibody; Anticardiolipin antibody; Antiphospholipid syndrome diagnosis; Obstetrical antiphospholipid syndrome; Thrombotic antiphospholipid syndrome

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; EUROPE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; THROMBOSIS;

EID: 67749101879     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-01-0043     Document Type: Article

References (24)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
3. Kist WJ, Janssen NG, Kalk JJ, et al. Thrombophilias and adverse pregnancy outcome - A confounded problem! Thromb Haemost 2008; 99: 77-85.
4. Tincani A, Bazzani C, Zingarelli S, et al. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis and treatment. Sem Thromb Haemost 2008; 34: 267-273.
5. Galli M, Reber G, De Moerloose P, et al. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008; 6, 399-401.
6. Boffa MC, Aurousseau MH, Lachassinne E, et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004; 13: 713-717.
7. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a ooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-583.
8. Balestrieri G, Tincani A, Spatola L, et al. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-130.
9. Roussel V, Yi F, Jauberteau MO, et al. Prevalence and clinical significance of phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoiommun 2000; 14: 259-265.
10. Cucnik S, Ambrozic A, Bozic B, et al. Antibeta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med 2000; 38: 777-783.
11. Nicaise-Roland P, Aurousseau MH, Delaval A, et al. Levels of anticardiolipin and anti-beta2-glycoprotein1 antibodies in healthy new-born cord sera. Thromb Haemost 2008; 99: 1124-1126.
12. 2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2002; 20: 101-108.
13. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants an update. Thromb Haemost 1995; 74: 1185-1190.
14. Pourrat O, Jollit C, Gombert JM, et al. Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetrical medicine clinic series of 107 patients. J Thromb Haemost 2006; 4: 295-306.
15. Moffat KA, Ledford-Kraemer MR, Plumhoff EA et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost 2009; 101: 178-184.
16. Tebo AE, Jaskowski TD, Phansalkar AR, et al. Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome. Am J Clin Pathol 2008; 129: 870-875.
17. Reber G, Tincani A, Sanmarco M, et al. European Forum on Antiphospholipid Antibodies Standardization Group. Variability of anti-beta2-glycoprotein I measurement by commercial assays. Thromb Haemost 2005; 94: 665-672.
18. Sanmarco M, Bardin N, Blank M, et al. Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. Thromb Haemost. 2005; 93: 80-87.
19. Reber G, Shousboe I, Tincani A, et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002; 88: 66-73.
20. 2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-1862
21. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-558.
22. Avcin T. Antiphospholipid syndrome in children. Curr Opin Rheumatol 2008; 20: 595-600.
23. Bauersachs RM, Dudenhausen J, Faridi A, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98: 1237-1245.
24. Sanmarco M, Gayet S, Alessi MC, et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost 2007; 97: 949-954.